Edgewise Therapeutics, Inc. (EWTX)
29.31
-0.20
(-0.68%)
USD |
NASDAQ |
Feb 20, 16:00
29.27
-0.04
(-0.14%)
After-Hours: 20:00
Edgewise Therapeutics SG&A Expense (Quarterly) : 9.378M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Glaukos Corp. | 94.70M |
| Nuvalent, Inc. | 28.85M |
| Neurocrine Biosciences, Inc. | 301.80M |
| Dynavax Technologies Corp. (DELISTED) | 40.09M |
| Omeros Corp. | 10.40M |